https://mdtechcouncil.com/maryland-tech-council-announces-2024-icon-award-finalists/
GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)
GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)
June 03, 2020
GlycoMantra was awarded a SBIR Phase 1 grant to investigate insulin resistance in type 2 diabetes.